CAMP — CAMP4 Therapeutics Balance Sheet
0.000.00%
- $39.31m
- -$24.56m
- $0.65m
Annual balance sheet for CAMP4 Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Cash and Equivalents | |||
Cash and Short Term Investments | 83.2 | 38.4 | 64 |
Net Total Receivables | 0.84 | 0.922 | 1.09 |
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 84.4 | 40 | 66.4 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 16.8 | 13.3 | 10.3 |
Other Long Term Assets | |||
Total Assets | 103 | 54.9 | 78.3 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 7.95 | 7.81 | 9.6 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Total Other Liabilities | |||
Total Liabilities | 17.9 | 16.5 | 15.2 |
Redeemable Preferred Stock | |||
Non Redeemable Preferred Stock | |||
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Other Equity | |||
Total Equity | 84.6 | 38.4 | 63.1 |
Total Liabilities & Shareholders' Equity | 103 | 54.9 | 78.3 |
Total Common Shares Outstanding |